8-K: IIOT-OXYS Inc. Forgives Debt Through Issuance of Series C Preferred Stock

IIOT-OXYS Inc. has agreed to issue 57 shares of Series C Preferred Stock to Cambridge MedSpace LLC in exchange for the forgiveness of $68,825 in debt.

Summary

• IIOT-OXYS Inc. entered into a Debt Exchange Agreement on February 5, 2024, which was approved and ratified by the board on March 7, 2024.
• Under the agreement, the company will issue 57 shares of Series C Preferred Stock to Cambridge MedSpace LLC.
• This issuance is in exchange for the forgiveness of $68,825 of debt, which includes $55,000 of principal and accrued unpaid interest.
• Cambridge MedSpace LLC is an entity in which the CEO of IIOT-OXYS, Clifford L. Emmons, shares ownership.
• The sale of these shares is exempt from registration under the Securities Act of 1933, specifically under Section 3(a)(9).

Sentiment

Score: 5

Explanation: The document indicates a debt reduction, which is positive, but the related-party nature of the transaction and the dilution of equity are concerning. The overall sentiment is neutral.

Positives

• The company is reducing its debt by $68,825.
• The debt reduction is achieved through the issuance of preferred stock, which may be less burdensome than cash repayment.
• The transaction is exempt from registration, simplifying the process.

Negatives

• The company is issuing preferred stock, which could dilute existing shareholders' equity.
• The debt is being forgiven by an entity related to the CEO, which could raise questions about potential conflicts of interest.

Risks

• The issuance of preferred stock could dilute the ownership of existing shareholders.
• The related-party nature of the transaction could raise concerns about fairness and transparency.
• The company's financial situation may be precarious if it needs to resort to debt-for-equity swaps.

Management Comments

• The board of directors approved and ratified the Debt Exchange Agreement.

Industry Context

Debt-for-equity swaps are not uncommon for companies facing financial challenges, particularly in the technology and biotech sectors. This transaction is a way for IIOT-OXYS to reduce its debt burden, but it also dilutes existing shareholders.

Comparison to Industry Standards

• Similar debt-for-equity swaps have been seen in other small-cap companies facing financial constraints.
• The valuation of the preferred stock issued in exchange for debt is not disclosed, making it difficult to assess the fairness of the transaction compared to industry benchmarks.
• Companies like Xometry and Desktop Metal have also used similar strategies to manage debt, but the specific terms and conditions vary widely.

Related Party Transactions

• The debt forgiveness is with Cambridge MedSpace LLC, an entity in which the company's CEO, Clifford L. Emmons, shares ownership.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of preferred stock.
• Creditors may view the debt reduction positively.
• Employees may be indirectly affected by the company's financial restructuring.

Key Dates

Keywords

Debt Exchange, Preferred Stock, Debt Forgiveness, Related Party Transaction, Equity Securities, IIOT-OXYS, Cambridge MedSpace